Lipid vesicles for skin delivery of drugs: reviewing three decades of research.
Since liposomes were first shown to be of potential value for topical therapy by Mezei and Gulasekharam in 1980, studies continued towards further investigation and development of lipid vesicles as carriers for skin delivery of drugs. Despite this long history of intensive research, lipid vesicles are still considered as a controversial class of dermal and transdermal carriers. Accordingly, this article provides an overview of the development of lipid vesicles for skin delivery of drugs, with special emphasis on recent advances in this field, including the development of deformable liposomes and ethosomes.
Elsayed
Mustafa M A
MM
Department of Pharmaceutics, Faculty of Pharmacy, University of Alexandria, El-Khartoum Square, El-Azarita, Alexandria 21521, Egypt. mmaelsayed@gmail.com
Abdallah
Ossama Y
OY
Naggar
Viviane F
VF
Khalafallah
Nawal M
NM
D000279:Administration, Cutaneous; D000818:Animals; D004337:Drug Carriers / Q000266:history; D004339:Drug Compounding; D000431:Ethanol / Q000737:chemistry; D049673:History, 20th Century; D049674:History, 21st Century; D006801:Humans; D008081:Liposomes / Q000266:history; D010316:Particle Size; D010743:Phospholipids / Q000737:chemistry* / Q000378:metabolism; D012869:Skin Absorption; D012997:Solvents / Q000737:chemistry; D013678:Technology, Pharmaceutical / Q000266:history / Q000379:methods
D004337:Drug Carriers; D008081:Liposomes; D010743:Phospholipids; D012997:Solvents; D000431:Ethanol